AI assistant
Life360, Inc. — Director's Dealing 2021
May 6, 2021
30724_rns_2021-05-06_ee78e29f-c2bf-425f-aad2-21b4feb525c2.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity: Life360, Inc.
ARBN: 629 412 942
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | James Synge |
|---|---|
| Date of last notice | 16/03/2021 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
- |
| Date of change | 29/04/2021 (PDT) |
| No. of securities held prior to change | • 1,441,041 Chess Depositary Interests (CDIs) • 12,817 Shares of Common Stock (Shares)(equivalent to 38,451 CDIs) • 64,379 Shares (equivalent to 193,137 CDIs) held by ICCA Labs, LLC • 161,720 CDIs held by Stynge Pty Ltd ATF Sandy Bay Trust. • 2,189 Restricted Stock Units (RSUs) |
| Class | Options over Shares (Options) & RSUs |
| Number acquired | 12,203 Options 1,881 RSUs |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Number disposed | - |
|---|---|
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
Options and RSUs are granted for no consideration. Each option has an exercise price of $US13.35. Options and RSUs have been granted in lieu of the payment of Directors’ fees1 |
| No. of securities held after change | • 1,441,041 CDIs • 12,817 Shares (equivalent to 38,451 CDIs) • 64,379 Shares (equivalent to 193,137 CDIs) held by ICCA Labs, LLC • 161,720 CDIs held by Stynge Pty Ltd ATF Sandy Bay Trust. • 4,070 RSUs • 12,203 Options |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
Granting of options and RSUs approved at the 2021 AGM and issued under Restated and amended 2011 Stock Plan. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder (if issued securities) |
N/A |
| Date of change | N/A |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
N/A |
1 1,881 RSUs were granted in lieu of the payment of US$25,110 of Director and Committee Fees. 12,203 Options were granted in lieu of the payment of US$58,590 of Director and Committee Fees.
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
Interest after change N/A
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? |
No. |
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
N/A |
| If prior written clearance was provided, on what date was this provided? |
N/A |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3